Search Results

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.

Invivyd, Inc. announced that the U.S. Centers for Medicare & Medicaid Services has granted a Healthcare Common Procedure Coding System Q code covering product reimbursement for PEMGARDA.

Helius Medical Technologies, Inc. announced that the Centers for Medicare & Medicaid Services has assigned Healthcare Common Procedure Coding System Level II codes A4593, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime” to describe the PoNS controller and A4594, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each” to describe the PoNS mouthpiece.

Bionano Laboratories, a clinical laboratory services business of Bionano Genomics, Inc., announced the editorial panel of the American Medical Association established a new Category I Current Procedural Terminology code for the use of optical genome mapping in cytogenomic genome-wide analysis to detect structural and copy number variations related to hematological malignancies.